Mixlab, the leading modern veterinary pharmacy, today announced the upcoming launch of Maisy, its AI health partner designed to support veterinarians and animal owners throughout the medication journey. The announcement follows a year of significant growth as Mixlab continues to scale its technology-first approach to veterinary pharmacy.

In 2025, Mixlab partnered with more than 30,000 prescribers, more than doubling its network year over year, and supported the care of over 140,000 animals, representing nearly 75% growth. This momentum underscores increasing demand for a trusted, tech-enabled pharmacy partner among veterinarians and animal owners alike.

Strategic Partnerships to Improve Workflow Efficiency

Mixlab continued to deepen its technology integrations with other leading veterinary platforms, including Vetcove, Vetsource, and Instinct EMR. These integrations enable veterinarians to submit prescriptions directly within their existing workflows, increasing access while improving speed, accuracy, and prescription compliance.

Acquisitions to Expand into Key Markets

Following its 2024 acquisition of NexGen Animal Health in Texas, Mixlab acquired The Pet Apothecary in Wisconsin in early 2025, opening its fifth lab in the Midwest. Later in the year, Mixlab ensured continuity of patient care following the closure of two local veterinary compounding pharmacies: Animal Pharm in Massachusetts and Valley Drug Compounding Pharmacy (VDCrx) in California. Together, these acquisitions expanded Mixlab’s regional presence and nationwide operational capacity, while delivering an improved pharmacy experience through enhanced technology.

Product Innovation and AI to Power the Next Phase of Growth

Mixlab redesigned its proprietary prescription management platform for veterinarians, eMix, to feature a modern, mobile-friendly interface with AI-powered capabilities. The updated platform enables veterinarians to prescribe more efficiently, browse Mixlab’s full catalog and increase medication compliance. With up to one minute saved per prescription, Mixlab returned the equivalent of nearly a full year of combined time savings to veterinarians through more efficient workflows.

On the animal owner side, Mixlab launched a new browsable shopping experience alongside a prescription request workflow that integrates seamlessly with eMix. Veterinarians can review and approve requests with a single click, making it easier for owners to manage their animals’ medications while maintaining veterinarian oversight.

Introducing Maisy, Mixlab’s AI Health Partner

Building on these technology enhancements, Mixlab is preparing to launch Maisy, an AI health partner designed to support prescribers throughout the pharmacy experience. Maisy will leverage Mixlab’s first-party data, pharmacy expertise and prescribing infrastructure to help answer common medication questions, reinforce compliance and provide proactive support, all while working hand in hand with veterinarians.

“We are making long-term investments in technology with a clear focus on supporting veterinarians and improving the pharmacy experience,” said Fred Dijols, CEO of Mixlab. “Our data and infrastructure uniquely position us to apply AI in practical ways to support better outcomes. Maisy is a natural extension of that work: an AI health partner built to enhance care while keeping veterinarians firmly at the center.”

Looking ahead, Mixlab will continue to expand its technology platform and pharmacy operations as it advances its mission to redefine the veterinary pharmacy experience.

About Mixlab

Mixlab is the leading modern veterinary pharmacy that partners with veterinarians to streamline their processes and deliver the highest level of care to animal owners. Mixlab is digitally transforming the veterinarian-led medication process while delivering a superior customer experience. Founded in 2017, Mixlab operates five pharmacies and delivers across all 50 states. Mixlab has financial backing from Vanterra Ventures, Global Founders Capital, Sonoma Brands, PLUS Capital, Lakehouse Ventures, Monogram Capital, Alaric Capital, Brand Foundry, and others. Read more about Mixlab at www.mixlab.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260114551647/en/

Maisy will leverage Mixlab’s first-party data, pharmacy expertise and prescribing infrastructure.